Viewing StudyNCT00005023

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00005023
Status: COMPLETED
Last Update Posted: 2017-11-30
First Post: 2000-04-06
Brief Title: Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
Sponsor: University of Washington
Organization: University of Washington
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Ovarian Cancer
Breast Cancer
Lung Cancer
Keywords:
Name View
stage IV breast cancer View
stage IIIA breast cancer View
stage III non-small cell lung cancer View
stage IIIB breast cancer View
stage III ovarian epithelial cancer View
stage IV ovarian epithelial cancer View
stage IV non-small cell lung cancer View
adenocarcinoma of the lung View